Organogenesis Expands into Smithfield with Major Lease Agreement
Deal News | May 15, 2025 | Davis Cos/The
The Davis Companies (Davis) has announced a significant lease agreement with Organogenesis Holdings Inc. (Organogenesis) for a full-building at 100 Technology Way, Smithfield, Rhode Island. Organogenesis, a leader in regenerative medicine, will expand its biomanufacturing capabilities into the approximately 123,000-square-foot facility. This expansion underscores Organogenesis' commitment to enhancing their production lines while investing in New England's economy. The agreement is a testament to Davis' strategic focus on fostering innovative business environments within competitive markets. A multi-year construction project is set to transform the facility into a state-of-the-art cGMP space, with essential infrastructure to support biomanufacturing operations. The facility’s location is strategically beneficial, providing superior access to Cambridge and Boston compared to other regional sites. Representation for the deal included industry experts from JLL and Newmark, ensuring the effective facilitation of this prime real estate lease.
Sectors
- Biomanufacturing
- Regenerative Medicine
- Real Estate
Geography
- United States – The lease agreement and subsequent expansion activities are taking place in Rhode Island, with broader implications for the New England region.
- Rhode Island – The article specifies that the biomanufacturing facility is located in Smithfield, Rhode Island.
- New England – The expansion is positioned as a local economic investment in New England, highlighting its geographical importance.
Industry
- Biomanufacturing – The article highlights Organogenesis' expansion into 100 Technology Way to increase its biomanufacturing capabilities, emphasizing the significance of this industry.
- Regenerative Medicine – Organogenesis is identified as a leading company in regenerative medicine, indicating the relevance of this industry in the article's context.
- Real Estate – The article discusses a full-building lease agreement in Smithfield, RI, showcasing the role of the real estate industry in facilitating the expansion of biomanufacturing facilities.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Organogenesis Holdings Inc. | Tenant | Company | A leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for Advanced Wound Care and Surgical & Sports Medicine markets. |
| Davis Companies | Landlord | PE Firm | A real estate private equity firm that secured a full-building lease agreement with Organogenesis. |
| JLL | Represented Organogenesis | Company | A global professional services firm that represented Organogenesis in the lease agreement. |
| Newmark | Represented Davis | Company | A global real estate services company that represented Davis Companies in the lease agreement. |